Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weifuchun for different degrees of atrophic gastritis
ChiCTR2400091096Phase 4Not yet recruiting
- Sponsor
- Xi'an Aerospace General Hospital
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of weifuchun in atrophic gastritis (AG), sponsored by Xi'an Aerospace General Hospital. Primary endpoint: Histopathologic severity of gastric mucosal atrophy and intestinal metaplasia. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
weifuchun
03
Conditions
atrophic gastritis (AG)
Beyond the preview
Go deeper on ChiCTR2400091096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400091096.